Skip to main content
Bobby Liaw, MD, Oncology, New York, NY

BobbyChi-HungLiawMD

Oncology New York, NY

Genitourinary Oncology, Hematologic Oncology, Sarcoma

Site Chief, Mount Sinai Downtown; Clinical Director of Genitourinary Oncology, Mount Sinai Health System

Overview of Dr. Liaw

Dr. Bobby Liaw is an oncologist in New York, NY and is affiliated with multiple hospitals in the area, including The Mount Sinai Hospital, Mount Sinai West, Mount Sinai Morningside, Mount Sinai Beth Israel, Mount Sinai Hospital of Queens, New York Eye and Ear Infirmary of Mount Sinai, and Mount Sinai Brooklyn. He received his medical degree from State University of New York Downstate Medical Center College of Medicine and has been in practice 8 years. He is one of 190 doctors at The Mount Sinai Hospital and one of 124 doctors at Mount Sinai Beth Israel who specialize in Oncology. He also speaks multiple languages, including Chinese (Mandarin). He has more than 20 publications and over 250 citings.

Education & Training

  • Icahn School of Medicine at Mount Sinai
    Icahn School of Medicine at Mount SinaiFellowship, Hematology and Medical Oncology, 2012 - 2015
  • Beth Israel Deaconess Medical Center
    Beth Israel Deaconess Medical CenterResidency, Internal Medicine, 2010 - 2012
  • Beth Israel Deaconess Medical Center
    Beth Israel Deaconess Medical CenterInternship, Internal Medicine, 2009 - 2010
  • State University of New York Downstate Medical Center College of Medicine
    State University of New York Downstate Medical Center College of MedicineClass of 2009, MD
  • Cornell University
    Cornell UniversityBS, Biochemistry, 2001 - 2005

Certifications & Licensure

  • FL State Medical License
    FL State Medical License 2020 - Present
  • NY State Medical License
    NY State Medical License 2012 - 2025
  • MA State Medical License
    MA State Medical License 2009 - 2012
  • American Board of Internal Medicine Internal Medicine

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • The Role of Ketoconazole in Current Prostate Cancer Care  
    William Oh, Bobby Liaw, Vaibhav Patel, Nature

Press Mentions

  • What 5 Doctors Are Excited About in Kidney Cancer Research
    What 5 Doctors Are Excited About in Kidney Cancer ResearchSeptember 5th, 2024
  • Neuroimmunological Adverse Events Associated with Immune Checkpoint Inhibitor: A Retrospective, Pharmacovigilance Study Using FAERS Database
    Neuroimmunological Adverse Events Associated with Immune Checkpoint Inhibitor: A Retrospective, Pharmacovigilance Study Using FAERS DatabaseJanuary 9th, 2021
  • FDA Approval for Darolutamide in Prostate Cancer
    FDA Approval for Darolutamide in Prostate CancerAugust 1st, 2019
  • Join now to see all

Other Languages

  • Chinese (Mandarin)